Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ferric Carboxymaltose vs Oral Ferrous Sulphate for Iron Deficiency Anemia in Pregnancy
NCT04976179Phase 3Completed
- Sponsor
- University of Lagos
- Start
- Aug 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by University of Lagos. Started Aug 2021; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04976179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976179.